HPLC Analysis and Pharmacokinetics of KAL-1120, a Novel Anti-inflammation Agent, in Rats
![]() |
Shin, Dae-Hwan
(CBITRC, College of Pharmacy, Chungbuk National University)
Lee, Jung-Yeol (CBITRC, College of Pharmacy, Chungbuk National University) Park, Seong-Hyeok (CBITRC, College of Pharmacy, Chungbuk National University) Lee, Gyeong-Bok (CBITRC, College of Pharmacy, Chungbuk National University) Han, Kun (CBITRC, College of Pharmacy, Chungbuk National University) Chung, Youn-Bok (CBITRC, College of Pharmacy, Chungbuk National University) |
1 | Q.W. Xie, Y. Kashiwarbara and C. Nathan, Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase, J. Biol. Chem., 269, 4705-4708 (1994). |
2 | K.M. Lee, B.S. Kang, H.L. Lee, S.J. Son, S.H. Hwang, D.S. Kim, J.S. Park and H.J. Cho, Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity, Eur. J. Neurosci., 19, 3375-3381 (2004). DOI |
3 | R. Schreck, P. Rieber and P.A. Baeuerle, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J., 10, 2247-2258 (1991). |
4 | K.N. Islam, S. Devaraj and I. Jialal, Alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells, Circulation, 98, 2255-2261 (1998). DOI ScienceOn |
5 | S.S. Han, K. Kim, E.R. Hahm, S.J. Lee, Y.J. Surh, H.K. Park, W.S. Kim, C.W. Jung, M.H. Lee, K. Park, J.H. Yang, S.S. Yoon, N.H. Riordan, H.D. Riordan, B.F. Kimler, C.H. Park, J.H. Lee and S. Park, L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60, J. Cell Biochem., 93, 257-270 (2004). DOI |
6 | G. Chen, J. Shi, M. Qi, H. Yin and C. Hang, Glutamine decreases intestinal nuclear factor kappa B activity and proinflammatory cytokine expression after traumatic brain injury in rats, Inflamm. Res., 57, 57-64 (2008). |
7 | S.K. Manna, N.K. Sah, R.A. Newman, A. Cisneros and B.B. Aggarwa, Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase, Cancer Res., 60, 3838-3847 (2000). |
8 | J. Adams, The development of proteasome inhibitors as anticancer drugs, Cancer Cell, 5, 417-421 (2004). DOI |
9 | R. Al-Ashy, I. Chakroun, M.E. El-Sabban and F.R. Homaidan, The role of NF-kappaB in mediating the antiinflammatory effects of IL-10 in intestinal epithelial cells, Cytokine, 36, 1-8 (2006). DOI |
10 |
P.A. Baeuerle and D. Baltimore, NF- |
11 | W. Wang, H.L. McLeod and J. Cassidy, Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5- fluorouracil in human colorectal cancer cell lines, Int. J. Cancer., 104, 504-511 (2003). DOI |
12 | J. Garcia-Trapero, F. Carceller, M. Dujovny and P. Cuevas, Perivascular delivery of neomycin inhibits the activation of NF-kappaB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury, Neurol. Res., 26, 816-824 (2004). DOI |
13 | B.H. Kim, A.M. Reddy, K.H. Lee, E.Y. Chung, S,M, Cho, H. Lee, K.R. Min and Y. Kim, Inhibitory mechanism of chroman compound on LPS-induced nitric oxide production and nuclear factor-kappaB activation, Biochem. Biophys. Res. Commun., 325, 223-228 (2004). DOI |
14 | J.H. Kwak, B.H. Kim, J.K. Jung, Y. Kim, J. Cho and H. Lee, Structure-activity relationships of 6-hydroxy-7- methoxychroman-2-carboxylic acid N-(substituted) phenylamides as inhibitors of nuclear factor-kappaB activation, Arch. Pharm. Res., 30, 1210-1215 (2007). DOI |
15 | M.J. Yin, Y. Yamamoto and R.B. Gaynor, The antiinflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta, Nature, 396, 77-80 (1998). DOI ScienceOn |
16 | A. Lang, M. Lahav, E. Sakhnini, I. Barshack, H.H. Fidder, B. Avidan, E. Bardan, R. Hershkoviz, S. Bar-Meir and Y. Chowers, Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells, Clin. Nutr., 23, 1199-1208 (2004). DOI |
17 | C. Guruvayoorappan and G. Kuttan, Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells, Integr. Cancer. Ther., 6, 258-270 (2007). DOI |
18 | Y.J. Suzuki and L. Packer, Inhibition of NF-kappa B transcription factor by catechol derivatives, Biochem. Mol. Biol. Int., 32, 299-305 (1994). |
19 | F. D'Acquisto, L. Sautebin, T. Iuvone, M. DiRosa and R. Carnuccio, Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factorkappaB activation in J774 macrophages, FEBS Lett., 440, 76-80 (1998). DOI |
20 | S. Okamoto, N. Mukaida, K. Yasumoto, N. Rice, Y. Ishikawa, H. Horiguchi, S. Murakami and K. Matsushima, The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization, J. Biol. Chem., 269, 8582-8589 (1994). |
21 | M. Severa, A. D'Ambrosio, L. Giordani, F. Quintieri and E. Coccia, Inhibition of interleukin-12 expression in diltiazemtreated dendritic cells through the reduction of nuclear factor-kappa B transcriptional activity, Biochem. Pharmacol., 69, 425-432 (2005). DOI |
![]() |